| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/05/2011 | US20110105570 Phosphodiesesterase 4 inhibitors for the treatment of a cognitive deficit |
| 05/05/2011 | US20110105569 Phosphodiesesterase 4 inhibitors for the treatment of a cognitive deficit |
| 05/05/2011 | US20110105568 Novel method for the production of sulphonylpyrroles as hdac inhibitors |
| 05/05/2011 | US20110105567 Pyrrole Compounds Having Sphingosine-1-Phosphate Receptor Agonist Or Antagonist Biological Activity |
| 05/05/2011 | US20110105565 Water soluble small molecule inhibitors of the cystic fibrosis transmembrane conductance regulator |
| 05/05/2011 | US20110105563 Il-8 receptor antagonists |
| 05/05/2011 | US20110105562 Alkynyl derivatives useful as dpp-1 inhibitors |
| 05/05/2011 | US20110105561 Serotonin transporter (sert) inhibitors for the treatment of depression and anxiety |
| 05/05/2011 | US20110105560 Treatment of cns disorders associated with mutations in genes encoding lysosomal enzymes |
| 05/05/2011 | US20110105559 Compositions and Methods for Treating, Controlling, Reducing, Ameliorating, or Preventing Allergy |
| 05/05/2011 | US20110105558 Eye-drop preparation and use thereof |
| 05/05/2011 | US20110105557 Farnesyl protein transferase inhibitor combinations with antiestrogen agents |
| 05/05/2011 | US20110105556 Tris-quarternary ammonium salts and methods for modulating neuronal nicotinic acetylcholine receptors |
| 05/05/2011 | US20110105555 Substituted n-imidazo[2,1-b]thiazole-5-sulfonamide derivatives as 5-ht6 ligands |
| 05/05/2011 | US20110105554 Means for treating myosin-related diseases |
| 05/05/2011 | US20110105553 New classes of gabaa/bzr ligands |
| 05/05/2011 | US20110105552 Beloxepin and analogs for the treatment of pain |
| 05/05/2011 | US20110105551 Analgesics for nasal administration |
| 05/05/2011 | US20110105550 Forms of rifaximin and uses thereof |
| 05/05/2011 | US20110105549 Branched 3- and 6-substituted quinolines as cgrp receptors antagonists |
| 05/05/2011 | US20110105548 N-aryl diazaspirocyclic compounds and methods of preparation and use thereof |
| 05/05/2011 | US20110105547 Filamin a-binding anti-inflammatory analgesic |
| 05/05/2011 | US20110105546 Spirotropane compounds |
| 05/05/2011 | US20110105545 GPBP inhibition using Q2 peptidomimetics |
| 05/05/2011 | US20110105544 Carboxylic derivatives for use in the treatment of cancer |
| 05/05/2011 | US20110105543 Novel triaryl derivatives useful as modulators of nicotinic acetylcholine receptors |
| 05/05/2011 | US20110105542 Pyrazolo--quinazolines |
| 05/05/2011 | US20110105541 ALKYL SUBSTITUTED ARYLINDENOPYRIMIDINES AND THEIR USE AS HIGHLY SELECTIVE ADENOSINE A2a RECEPTOR ANTAGONISTS |
| 05/05/2011 | US20110105540 2-AMINO-9-[4-(4-METHOXY-PHENOXY)-PIPERIDIN-1-YL]-4-PHENYL-INDENO[1,2-D]PYRIMIDIN-5-ONE AND ITS USE AS A HIGHLY SELECTIVE ADENOSINE A2a RECEPTOR ANTAGONIST |
| 05/05/2011 | US20110105539 2'-halobiphenyl-4-yl intermediates in the synthesis of angiotensin ii antagonists |
| 05/05/2011 | US20110105538 Drug response markers |
| 05/05/2011 | US20110105537 5,7-disubstituted thiazolo[4,5-d]pyrimidines for the selective inhibition of chemokine receptors |
| 05/05/2011 | US20110105536 Dosing regimen associated with long-acting injectable paliperidone esters |
| 05/05/2011 | US20110105535 Inhibitors of phosphatidylinositol 3-kinase |
| 05/05/2011 | US20110105533 Heterocyclic Sulfonamides, Uses and Pharmaceutical Compositions Thereof |
| 05/05/2011 | US20110105531 Compositions and methods for identification of subspecies characteristics of mycobacterium tuberculosis |
| 05/05/2011 | US20110105530 Organic compounds |
| 05/05/2011 | US20110105529 ERCC-1 Gene Expression Predicts Chemotherapy Outcome |
| 05/05/2011 | US20110105528 1-(7-(hexahydropyrrolo [3, 4-c] pyrrol-2 (1h)-yl) quinolin-4-yl) -3- (pyrazin-2-yl) urea derivatives and related compounds as glycogen synthase kinase 3 (gsk-3) |
| 05/05/2011 | US20110105527 Pyrazines as delta opioid receptor modulators |
| 05/05/2011 | US20110105526 Selective subtype alpha 2 adrenergic agents and methods for use thereof |
| 05/05/2011 | US20110105525 Pharmaceutical compositions containing a crystalline form of posaconazole |
| 05/05/2011 | US20110105524 Cysteine protease inhibitors |
| 05/05/2011 | US20110105523 Bifeprunox derivatives |
| 05/05/2011 | US20110105522 Ketoconazole-derivative antagonist of human pregnane x receptor and uses thereof |
| 05/05/2011 | US20110105521 Combination of (a) a phosphoinositide 3-kinase inhibitor and (b) a modulator of ras/raf/mek pathway |
| 05/05/2011 | US20110105520 Pyrimidine compounds as delta opioid receptor modulators |
| 05/05/2011 | US20110105519 Pharmaceutical Compositions for the Treatment of Sexual Disorders II |
| 05/05/2011 | US20110105518 Therapeutic agent for spinal canal stenosis |
| 05/05/2011 | US20110105517 Therapeutic agent for amyotrophic lateral sclerosis |
| 05/05/2011 | US20110105516 Polymerized micelles |
| 05/05/2011 | US20110105515 Targeting the oncoprotein nucleophosmin |
| 05/05/2011 | US20110105514 5,6,7,8-tetrahydro-imidazo[1,5-a]pyrazine compounds |
| 05/05/2011 | US20110105513 AMINO-QUINOXALINE AND AMINO-QUINOLINE COMPOUNDS FOR USE AS ADENOSINE A2a RECEPTOR ANTAGONISTS |
| 05/05/2011 | US20110105512 Bridged bicyclic heteroaryl substituted triazoles useful as axl inhibitors |
| 05/05/2011 | US20110105511 Polycyclic heteroaryl substituted triazoles useful as axl inhibitors |
| 05/05/2011 | US20110105510 Prophylactic/ameliorating or therapeutic agent for non-alcoholic steatohepatitis |
| 05/05/2011 | US20110105509 Indole based receptor crth2 antagonists |
| 05/05/2011 | US20110105508 Quinoxaline and quinoline derivatives as kinase inhibitors |
| 05/05/2011 | US20110105507 Vinyl ether compounds and methods of their preparation and use |
| 05/05/2011 | US20110105506 Diaminoalkane aspartic protease inhibitors |
| 05/05/2011 | US20110105505 Thiazolyl piperidine derivatives |
| 05/05/2011 | US20110105504 Inhibitors Of 11beta-Hydroxysteroid Dehydrogenase Type 1 |
| 05/05/2011 | US20110105503 Aralkyl piperidine derivatives and their uses as antalgic or ataractic agent |
| 05/05/2011 | US20110105502 Tetrahydroisoquinolines, pharmaceutical compositions containing them, and their use in therapy |
| 05/05/2011 | US20110105501 Pharmaceutical combinations |
| 05/05/2011 | US20110105500 Pyrazine substituted purines |
| 05/05/2011 | US20110105499 Pyrazolo-Pyrazinone Compounds and Methods of Use Thereof |
| 05/05/2011 | US20110105498 Pyrazolo-pyridinone and pyrazolo-pyrazinone compounds as P38 modulators and methods of use thereof |
| 05/05/2011 | US20110105497 Compounds and methods for treatment of cancer |
| 05/05/2011 | US20110105496 Methods For The Treatment Of Myosin Heavy Chain-Mediated Conditions Using 4,7-Dihydrothieno[2,3-B]Pyridine Compounds |
| 05/05/2011 | US20110105495 CYCLOPENTATHIOPHENE MODULATORS OF THE GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-kB ACTIVITY AND USE THEREOF |
| 05/05/2011 | US20110105494 Heteroaryl substituted arylindenopyrimidines and their use as highly selective adenosine a2a receptor antagonists |
| 05/05/2011 | US20110105493 HETEROCYCLYL SUBSTITUTED ARYLINDENOPYRIMIDINES AND THEIR USE AS HIGHLY SELECTIVE ADENOSINE A2a RECEPTOR ANTAGONISTS |
| 05/05/2011 | US20110105492 ARYL SUBSTITUTED ARYLINDENOPYRIMIDINES AND THEIR USE AS HIGHLY SELECTIVE ADENOSINE A2a RECEPTOR ANTAGONISTS |
| 05/05/2011 | US20110105491 Thiazolidine compounds as orexin receptor antagonists |
| 05/05/2011 | US20110105490 2,3-dihydro-1h-isoindol-1-imine derivatives useful as thrombin par-1 receptor antagonist |
| 05/05/2011 | US20110105488 Substituted pyrrolidine and piperidine compounds, derivatives thereof, and methods for treating pain |
| 05/05/2011 | US20110105487 Filamin a binding anti-inflammatory and analgesic |
| 05/05/2011 | US20110105486 Thiazole derivatives |
| 05/05/2011 | US20110105485 Alpha-(N-Sulfonamido)Acetamide Derivatives as Beta-Amyloid Inhibitors |
| 05/05/2011 | US20110105484 Filamin a-binding anti-inflammatory analgesic |
| 05/05/2011 | US20110105483 Triazole compounds that modulate hsp90 activity |
| 05/05/2011 | US20110105482 Compositions of dual thyrointegrin antagonists and use in vascular-associated disorders |
| 05/05/2011 | US20110105481 Filamin a binding anti-inflammatory and analgesic |
| 05/05/2011 | US20110105480 Pharmaceutical transdermal compositions and method for treating inflammation in cattle |
| 05/05/2011 | US20110105479 Inhibitors of Bruton's Tyrosine Kinase |
| 05/05/2011 | US20110105478 Novel 1,4-diaza-bicyclo[3.2.2]nonyl oxadiazolyl derivatives useful as modulator of nicotinic acetylcholine receptors |
| 05/05/2011 | US20110105477 Compositions and methods relating to hiv protease inhibition |
| 05/05/2011 | US20110105476 Substituted 7,8-dihydro-1hpyrimido[4,5-b]diazepin-4-amines are novel kinase inhibitors |
| 05/05/2011 | US20110105475 Benzofurane, benzothiophene, benzothiazol derivatives as fxr modulators |
| 05/05/2011 | US20110105474 Heterocyclic derivatives as hdac inhibitors |
| 05/05/2011 | US20110105473 Macrocyclic indole derivatives useful as hepatitis c virus inhibitors |
| 05/05/2011 | US20110105471 Novel crystalline compound and a process for its preparation |
| 05/05/2011 | US20110105470 Novel Lapachone Compounds And Methods of Use Thereof |
| 05/05/2011 | US20110105469 Methods and compositions for the treatment of psychotic disorders through the identification of the sult4a1-1 haplotype |
| 05/05/2011 | US20110105468 Methods and compositions for the treatment of psychotic disorders through the identification of the sult4a1-1 haplotype |
| 05/05/2011 | US20110105467 Methods and compositions for the treatment of psychotic disorders through the identification of the sult4a1-1 haplotype |
| 05/05/2011 | US20110105466 Methods and compositions for the treatment of psychotic disorders through the identification of the sult4a1-1 haplotype |
| 05/05/2011 | US20110105465 Inhibitor of analgesic tolerance |